ロード中...
Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases
BACKGROUND: Krebs von den Lungen 6 (KL-6) is a sensitive marker for diagnosing, monitoring, and predicting the prognoses of interstitial lung diseases (ILDs). This study aimed to evaluate the performance of the Nanopia KL-6 assay (Sekisui Medical, Tokyo, Japan) and to test the relationship between K...
保存先:
| 出版年: | Ann Lab Med |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society for Laboratory Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6340849/ https://ncbi.nlm.nih.gov/pubmed/30623616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2019.39.3.245 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|